- 询价
- Agrisera
- 瑞典
- AS15 2869
- 2025年12月03日
- 0.2 µg/ml (WB)
- Goat
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant IFN-alpha88, produced in E.coli
- 形态：
Lyophilized in a carbonate buffer with NaCl and 0.02 % sodium azide, pH 8.0-8.5
- 保存条件：
Store lyophilized/reconstituted at -20°C; once rec
- 克隆性：
Polyclonal
- 适应物种：
Human
- 级别：
分子生物学级
- 供应商：
Agrisera
- 宿主：
Goat
- 应用范围：
0.2 µg/ml (WB)
- 靶点：
IFN alpha (interferon alpha) is produced by macrophages and have antiviral activities. It stimulated production of protein kinase and an oligoadenulate synthetase.
- 抗体名：
IFN alpha | Interferon alpha
- 规格：
100 µg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Measuring Interferon Alpha and Other Cytokines in SLE
The progression of disease in patients with systemic lupus erythematosus (SLE) is affected by production, accumulation, and actions of cytokines. Type I interferon (IFN), specifically IFN-α, is recognized as a central mediator of disease
motifs located prevalently in the 3′ untranslated regions of target messenger RNAs (mRNA). Interferon-alpha-2a (IFNα) induces a large set of protein coding genes mediating antiproliferative and antiviral responses. Here we use a global microarray-based
Interferon Alpha, GM-CSF-Activated T Cells, and IL-6 in Renal Cell Carcinoma
an optimal beneficial way of administering IL-2. In addition, investigation also led to other immunotherapy agents such as interferon and cellular therapy.
技术资料暂无技术资料 索取技术资料
